FDA approves drug for treating pancreatic cancer
Health regulators clear AstraZeneca and Merck treatment for disease projected to kill 46,000 Americans this year.
Related Articles
A multivalent mRNA-LNP vaccine protects against Clostridioides difficile infection
Clostridioides difficile infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)–lipid nanoparticle (LNP)…
Nearly 50% of researchers quit science within a decade, huge study reveals
Nature – Twenty years of publishing data across many countries and disciplines show women are more likely than men to leave research.
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution
Nature Genetics – Major histocompatibility complex (MHC) loss of heterozygosity, allele-specific mutation and measurement of expression and repression (MHC Hammer) detects disruption to human…
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions
Chemical screens identify drug sensitivities that vary in conventional versus Human Plasma–Like Medium (HPLM).
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels
How T cells are recruited to brain tumors from the blood remains unclear. Messmer et al. identify peritumoral venous vessels (PVVs) as key structures for T cell recruitment…
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution
Nature Genetics – Major histocompatibility complex (MHC) loss of heterozygosity, allele-specific mutation and measurement of expression and repression (MHC Hammer) detects disruption to human…
Nearly 50% of researchers quit science within a decade, huge study reveals
Nature – Twenty years of publishing data across many countries and disciplines show women are more likely than men to leave research.
50 years in the making: acp3U, an amino-acid-containing nucleoside, links N-glycans and RNA in glycoRNA
In a recent publication in Cell, Xie et al. report a sensitive and scalable method for the detection and characterization of native glycoRNAs and identify acp3U,…
New ovarian cancer jab could ‘wipe out’ the deadly disease
A world’s first vaccine for deadly ovarian cancer currently being developed in the UK could eradicate the deadly disease, researchers say.
Wafik El-Deiry: Toward a Biomedical Research Enterprise That Better Serves the United States – OncoDaily
Wafik El-Deiry: Toward a Biomedical Research Enterprise That Better Serves the United States / AACI, Albert Reece, American Association for Cancer Research,